Dealmaking

OTPP, Nordic Capital aim to expand Max Matthiessen's footprint into Northern Europe

Nordic Capital and OTPP agreed to take a co-control ownership of Max, a financial adviser for pensions, insurance and investments, in late-November.

GTCR reveals a big sale; the exit environment is likely to continue improving in 2025; plus what drove accounting deals in 2024

GTCR is selling insurance broker AssuredPartners for $13.45 billion.

Complex regulations, labor shortage, market fragmentation fueled PE interest in CPAs

Hellman & Friedman, Valeas Capital Partners, New Mountain Capital and Lovell Minnick Partners are some of the firms investing in this sector.

Bain Capital’s Sessa expects increased deal volume in 2025; CVC in talks to take healthcare software biz private

Keensight Capital has agreed to acquire a European human risk management software vendor.

Bain Capital’s Ivano Sessa: ‘Quietly confident’ on European dealmaking in 2025

Partner confident the firm can navigate the ‘no growth to very low growth’ predicted in Europe.

Quarterly M&A Deals: 2018-24

A look at private equity deals by quarter.

Will exit activity surge or sputter in 2025?

Because of their significance to the private equity industry, there will be a lot of eyes on exit trends in the months ahead.

RiverGlade, InTandem see add-on potential in infusion services; BCLP’s Schwartz on healthcare dealmaking scrutiny in '25

Private equity bets on healthcare infusion services.

Skepticism of PE-backed healthcare deals likely to continue under next FTC chair

BCLP's David Schwartz: 'The FTC has invested heavily in understanding and tracking private equity dealmaking in healthcare, and I do not see those investments being discarded just because of a change in administration.'

Private equity active in the infusion services market: 6 deals

RiverGlade Capital, InTandem Capital Partners and FFL Partners are among the firms looking to capitalize on infusion service investments.